Volume 6, Issue 1, January 2020, Page: 1-5
Synthesis of Novel Pyrimido Pyrimidine and Their Derivatives
Sirsat Shivraj Balajirao, P. G. Research Centre, Department of Chemistry, Yeshwant Mahavidyalaya, Nanded, India
Jadhav Anilkumar Govindrao, P. G. Research Centre, Department of Chemistry, Yeshwant Mahavidyalaya, Nanded, India
Nilesh B Chavhan, P. G. Research Centre, Department of Chemistry, Yeshwant Mahavidyalaya, Nanded, India
Received: Mar. 18, 2020;       Accepted: Apr. 1, 2020;       Published: Apr. 30, 2020
DOI: 10.11648/j.ijpc.20200601.11      View  276      Downloads  125
Abstract
Chalcone derivatives were synthesis by the reaction of some 4-nitrobenzaldehyde derivatives with acotophenone then the product obtained E-3-(4-nitrophenyl)-1-phenylprop-2-en-1-one. This product is chalcone is another react with guanidine nitrate. The hetrocyclic derivatives of guanidine nitrate respectively the final product have been characterized by elemental analysis. the product obtained is 1,6 dihydro 6(4-nitrophenyl) 4-phenylpyridine 2-amine. In present report novel pyrimidines were prepared from starting materials chalcone and guanidine nitrate. The resulting compound 1,6-dihydro-6-(4-nitrophenyl)-4 phenylpyrimidin 2 amine (2) was further reacted with 2 bis(methylthio)methylene malononitrile in the presence of catalytic amount of potassium carbonate in DMF under reflux condition that offered novel 4,6,9,9a-tetrahydro-4-imino-2-(methylthio)-8-(4-nitrophenyl) 6 phenyl 1H pyrimido[1,2 a]pyrimidine 3 carbonitrile (3). The synthesized compounds were characterized by spectral methods. The compound (3) possesses replaceable methylthio (-SCH3) group at 2 position. The compound (3) react with various nucleophiles like substituted aromatic amines, aromatic phenols, hetryl amines and active methylene compounds to give 4,6,9,9a-tetrahydro-4-imino-2-(methylthio)-8-(4-nitrophenyl)-6-phenyl-1H-pyrimido[1,2-a]pyrimidine-3-carbonitrile –carbonitrile in good yields.
Keywords
Claisen Schmidt Condensation, 2 bis(methylthio)methylene malononitrile Michael Addition Reaction, Pyrimidine
To cite this article
Sirsat Shivraj Balajirao, Jadhav Anilkumar Govindrao, Nilesh B Chavhan, Synthesis of Novel Pyrimido Pyrimidine and Their Derivatives, International Journal of Pharmacy and Chemistry. Vol. 6, No. 1, 2020, pp. 1-5. doi: 10.11648/j.ijpc.20200601.11
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Devprakash, AB Udaykumar, Journal of Pharmaceutical Research, 2011; 4 (7): 2436-2440.
[2]
T. Sasada, F. Kobayashi, N. Sakai, T. Konakahara, Organic Letters, 2009; 11: 2161-2164.
[3]
FL Rodney, G Charles, Skinner, S William, Canadian Journal of Chemistry, 1967; 45: 2213-2216.
[4]
VP Litvinov, Advances in Heterocyclic Chemistry, vol. 92, Zelinsky Institute of Organic chemistry, Russian Academy of Sciences, 119991 Moscow, Russia, 2006; 83.
[5]
Amir M, Javed SA and Kumar H; Indian J. Pharm. Sciences, 2007; 69 (3): 337-343.
[6]
O Stanisaw, (2009), some biologically active pyrimidine derivatives are prazosin, quinethazone trimethotrexate, folic acid, riboflavin, Jord. J. Chem, 4: 1-15.
[7]
Jain MK, Sharnevas SC; Organic Chem.; 2008; 3; 997-999.
[8]
Desai K, Patel R, Chikhalia K. J Ind Chem, 2006; 45: 773-778.
[9]
Amr EA, Nermien MS, Abdulla MM. Monatsh Chem, 2007; 138: 699-707.
[10]
Fujiwara N, Nakajima T, Ueda Y, Fujita HK, Awakami H. Bioorg Med Chem, 2008; 16: 9804-9816.
[11]
Ballell L, Field RA, Chung GAC, Young RJ. Bioorg Med Chem Lett, 2007; 17: 1736-1740.
[12]
Wagner E, Al-Kadasi K, Zimecki M, Sawka-Dobrowolska W. Eur J Med Chem, 2008; 43: 2498-2504.
[13]
Jean-Damien C, David B, Ronald K, Julian G, Pan L, Robert D. Vertex Pharmaceuticals Incorporated, USA, PCT Int. Appl. 2002; 22: 608.
[14]
Gorlitzer K, Herbig S, Walter RD. Pharmazie, 1997; 52: 670-672.
[15]
Ukrainets IV, Tugaibei IA, Bereznykova NL, Karvechenko VN, Turov AV. Khimiya Geterotsiklicheskikh Soedinenii, 2008; 5: 718-729.
[16]
Kurono M, Hayashi M, Miura K, Isogawa Y, Sawai K, Kokai Tokkyo Koho JP 1987; 62: 267-272, Chem. Abstr, 1988; 109: 37832.
[17]
Wang SQ, Fang L, Liu XJ, Zhao K. Chinese Chem Lett, 2004; 15: 885-888.
[18]
Yang W, Ruan Z, Wang Y, Van Kirk K, Ma Z, Arey BJ. et al. J Med Chem, 2009; 52: 1204-1208.
[19]
Gillespie RJ, Bamford SJ, Botting R, Comer M, Denny S, et al. J Med Chem, 2009; 52: 33-47
[20]
A Hausen, D Fuchs, G Reibnegger, H Wachter, Cancer, 1984, 53 (7), 1634-6.
[21]
T Netzer, F Ullrich, H Priewer, M Majewski, E Mutschler, Brit. J. Pharmac, 1992; 106 (1): 222–226.
[22]
Y Zheng, M Sun, Y Liu, M Li, M Ji, Med. Chem, 2011; 7 (4): 295-300.
[23]
K Sushil, Kashaw, G Vivek, K Varsha, P Mishra, JP Stables, NK Jain, Med. Chem. Research, 2010; 19: 250-261.
[24]
DW Combs, MS Rampulla, RK Russell, RA Rampulla, DH Klaubert, D Ritchie, AS Meeks, T Kirchner, Drug Design Delivery, 1990; 6 (4): 241-254.
[25]
AR Katritzky, CW Rees, EFV Scriven, Comprehensive Heterocyclic Chemistry II, Boulton, A. J., Ed., 6, Pergamon Press: Oxford – New York – Tokyo, 1996; 195-231.
[26]
G Jian, Z Quan, ON Michael, O Nicanor, A Arba, G Lucia, AJ Lin, Antimicrobial Agents and Chemotherapy, 2005; 49: 4928-4933.
[27]
O Stanisaw, Jord. J. Chem, 2009; 4: 1-15.
Browse journals by subject